SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients

Mostrar otras versiones (1)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), emerged at the end of 2019 and by mid-June 2020 the virus had spread to at least 215 countries, caused more than 8 000 000 confirmed infections and over 450 000 deaths, and overw...

Descripción completa

Detalles Bibliográficos
Autores principales: Klimstra, William B., Tilston-Lunel, Natasha L., Nambulli, Sham, Boslett, James, McMillen, Cynthia M., Gilliland, Theron, Dunn, Matthew D., Sun, Chengun, Wheeler, Sarah E., Wells, Alan, Hartman, Amy L., McElroy, Anita K., Reed, Douglas S., Rennick, Linda J., Duprex, W. Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Microbiology Society 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879561/
https://www.ncbi.nlm.nih.gov/pubmed/32821033
http://dx.doi.org/10.1099/jgv.0.001481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879561/
https://www.ncbi.nlm.nih.gov/pubmed/32821033
http://dx.doi.org/10.1099/jgv.0.001481

Ejemplares similares